Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2022-02-04 Share Issue/Capital Cha…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
220204 - Disposals of own shares_ENG.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "Disposals of own shares" and details transactions where the company disposed of its own shares following the exercise of stock options by personnel under incentive programs. This directly matches the definition for 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities by the company itself. The document is short and contains the transaction details, confirming it is the primary announcement, not just a notice of publication.
2022-02-04 English
220204 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA alienated treasury shares following the exercise of employee stock options. This directly relates to the company buying back or issuing its own shares for internal purposes (like compensation delivery). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal regulatory disclosure regarding share transactions, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2022-02-04 French
220204 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB shares were delivered to employees as part of long-term incentive plans (stock options). This directly relates to the company buying back or issuing its own shares, specifically in the context of employee stock option exercises resulting in share delivery. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and appears to be a regulatory disclosure of these specific transactions.
2022-02-04 Dutch
220202 - Transparency notification press release FMR LLC .pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Transparency notification' from FMR LLC to UCB SA/NV, dated February 2, 2022, regarding a change in shareholding that crossed the 5% threshold downwards on January 27, 2022. This type of filing, which reports personal share transactions by executives or significant shareholders (insiders) crossing regulatory ownership thresholds, directly corresponds to the 'Director's Dealing' or 'Major Shareholding Notification' categories. Since the content explicitly details the crossing of a major shareholding threshold (5%) and lists the holdings of various affiliates under the umbrella of FMR LLC, it fits the definition of Major Shareholding Notification (MRQ) best, as it is a notification of a change in significant share ownership levels. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific regulatory disclosure about ownership changes.
2022-02-02 English
220202 - Notification de transparence comm. de presse FMR LLC .pdf
Major Shareholding Notification Classification · 99% confidence The document is a 'Déclaration de transparence' (Transparency Declaration) issued by FMR LLC regarding its shareholding in UCB SA. It explicitly states that FMR LLC's voting shareholding has crossed the 5% threshold downwards ('Seuil franchi : 5%', 'Dernière participation : 4,98%'). This type of filing, which reports changes in significant share ownership levels by an external entity, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS category.
2022-02-02 French
220202 - Transparantieverklaring persbericht FMR LLC .pdf
Major Shareholding Notification Classification · 99% confidence The document is a 'Transparantieverklaring' (Transparency Declaration) from UCB NV, announcing that FMR LLC has notified them of a change in their shareholding, specifically crossing below the 5% threshold on January 27, 2022. This type of filing, which reports changes in significant share ownership by an entity or individual, directly corresponds to the definition of a Major Shareholding Notification (MRQ). The content details the previous and current number of voting rights held by various related entities under the FMR LLC umbrella, confirming it is a notification of a change in significant shareholding.
2022-02-02 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.